Month: August 2018
-
Smartphone Device IDs Dangerous Mosquitoes
A study shows a smartphone-based system can quickly and inexpensively identify the species of mosquito that carries many infectious diseases, as well as a natural enemy of those mosquitoes.
-
Ideas For Taking Your Firm To The Next Level
As the infographic explains, we live in the digital age, and the business landscape evolves every day.
-
FDA to Test New Trial Designs, Assess A.I. Models
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics.
-
Top Careers for People Invested in Helping Others
If you want to make the world a better place for people to live in, here are a couple of careers that can have a positive impact on the lives of numerous individuals.
-
Genomics-Blockchain Company Launches, Raises $4.3 Million
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing.
-
Non-Invasive Imaging Technology Probes Deeper Into Tissue
An imaging process that combines ultrasound and lasers is shown in tests with lab samples and in animals to provide clearer and more detailed images of tissue deeper in the body.
-
Surviving The Dreaded Layoff In Your Twenties
We pulled together a few pieces of advice that will help you make the most of your time off work while forever staying focused on what lies ahead.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
Four Things Not to Do When Firing Someone
As long as the process has been approached in the right way, you need to think about firing people in the right way.
-
A.I., Imaging Shown to Predict Immunotherapy Success
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers.